About us
At "Exosomica", we are dedicated to advancing the fight against Parkinson’s disease. As a biotechnology startup, our mission is to develop and commercialize advanced therapies that will help those affected by this debilitating disease.
We are passionate about our work and believe that our therapies have the potential to make a real difference in the lives of those who suffer from Parkinson’s. With a team of visionary scientists and dedicated researchers, we are pushing the boundaries of what is possible in biotechnology.
"Exosomica" was founded in 2019 by Dr. Augustas Pivoriūnas, the leading stem cell researcher in Lithuania and the science management, consulting and investment company.
"Exosomica" has received a nearly 1 Mio EUR investment throu EU funds for a research project. During the project, Exosomica aims to develop the technology for the production and therapeutic use of small-scale laboratory exosomes.
We believe that our the new technology will help for millions people who are suffering from Parkinson`s decease.